Mr. Roche has been a member of our board of directors since joining in December 2016. An experienced life sciences industry executive, Mr. Roche is the founding member of Robert Roche Associates LLC, a consulting firm providing guidance to the pharmaceutical and healthcare industries that he created upon his retirement from Cephalon Inc. in February 2010. Mr. Roche joined Cephalon in January 1995 as the vice president, sales and marketing and was named executive vice president, worldwide pharmaceutical operations in 2005 where he was responsible for the establishment, management and leadership of the company’s global commercial activities. Prior to Cephalon, Mr. Roche served as director and vice president, worldwide strategic product development for SmithKline Beecham’s central nervous system and gastrointestinal products business. He also was managing director of SmithKline’s pharmaceutical operations in the Philippines. Prior to that, he held senior marketing positions in Canada and Spain, and had product planning responsibilities for SmithKline in Latin America. Mr. Roche began his pharmaceutical career in 1982 with SmithKline & French as a U.S. pharmaceutical sales representative. In addition to the Egalet board of directors, Mr. Roche is a member of the board of directors of Antares Pharma, Aratana Therapeutics, and Paragon Bioservices, Inc. and Bryn Mawr Hospital. Mr. Roche is a graduate of Colgate University and earned an MBA from The Wharton School at the University of Pennsylvania.

 Life Science